Natriuresis-Guided Diuretic Therapy for Heart Failure

(SAND-HF Trial)

This trial seeks better methods to adjust diuretic medication (water pills) for people with heart failure, aiming to reduce symptoms and avoid hospital visits. Researchers will examine how urine sodium levels can guide medication adjustments. Participants will join one of three groups: two groups will have their medication adjusted based on sodium levels using natriuresis-guided down-titration or up-titration, while the third group will be observed without changes. People with heart failure who use loop diuretics and live in specific regions may be suitable for this study. As an unphased trial, this study allows participants to contribute to innovative research that could enhance heart failure management.

The trial does not specify if you need to stop your current medications, but it does require that you are already using loop diuretics and have a stable dose of furosemide for at least one week or one month, depending on the group.

In a previous study, researchers examined the safety of adjusting diuretic doses based on urine sodium levels. For the method that increases diuretic doses, results showed a 64% increase in sodium removal from the body, indicating effective fluid removal. Researchers monitored possible side effects like low potassium levels, low blood pressure, and changes in kidney function, but specific data on their frequency was not provided.

The safety of decreasing diuretic doses remains unclear. Some experts believe more research is needed to fully understand the risks and benefits of reducing diuretic doses in people with heart failure.

Researchers are excited about this trial because it uses natriuresis-guided therapy to personalize diuretic doses for heart failure patients. Unlike standard treatments that rely on fixed diuretic dosing, this approach adjusts doses based on urine sodium levels, aiming for a more tailored and potentially more effective management of fluid balance. This could lead to better symptom control and fewer side effects, offering a promising advancement over traditional methods. By using a point-of-care sensor to measure urine sodium, the trial introduces a new way to optimize treatment in real-time, which could revolutionize how diuretics are used for heart failure.

Research has shown that using urine sodium levels to guide diuretic treatment in heart failure patients can be helpful. In this trial, participants in the Natriuresis-Guided Down-Titration group will have their medication reduced based on sodium levels, although studies have not found major differences in outcomes like weight loss or hospital stay compared to usual care. Meanwhile, participants in the Natriuresis-Guided Up-Titration group will have their medication increased using this method, which has shown promise. Specifically, studies found that patients had shorter hospital stays when their diuretic doses were increased based on sodium levels. Overall, this approach aims to better control fluid levels in heart failure, potentially improving patient outcomes.²⁶⁷⁸⁹